The knockout of these genes or the inhibition of mTOR signaling activity were sufficient to enhance memory-like CD4+ T cell responses and to provide prolonged help to CD8+ T cells to achieve target tumor cell killing, underscoring a central role for mTOR signaling in this context. The gene discussed is CD4; the disease is neoplasm.